乳腺癌是威胁女性健康的主要恶性肿瘤之一,其发病率占全身各种恶性肿瘤的7%~10%。目前常规的治疗手段包括传统的手术治疗以及术后化疗,以及雌、孕激素受体阳性的患者还可以选用的内分泌治疗。近年来,随着肿瘤分子生物学研究的日趋深入,乳腺癌的分子靶向治疗在乳腺癌治疗中越来 Breast cancer is one of the main malignant tumors which threaten the health of women. The incidence of breast cancer accounts for 7% -10% of all kinds of malignant tumors in the body. The current conventional treatment methods include traditional surgery and postoperative chemotherapy, and estrogen and progesterone receptor-positive patients can also choose the endocrine therapy. In recent years, with the development of tumor molecular biology, molecular targeted therapy of breast cancer has become more and more popular in the treatment of breast cancer